{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T11:49:18Z","timestamp":1790336958843,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,12,14]],"date-time":"2013-12-14T00:00:00Z","timestamp":1386979200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1007\/s12185-013-1487-5","type":"journal-article","created":{"date-parts":[[2013,12,13]],"date-time":"2013-12-13T10:23:53Z","timestamp":1386930233000},"page":"154-161","source":"Crossref","is-referenced-by-count":35,"title":["Liver disease is frequently observed in Down syndrome patients with transient abnormal myelopoiesis"],"prefix":"10.1007","volume":"99","author":[{"given":"Myoung Ja","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"Sotomatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Ohki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kokoro","family":"Arai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomio","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Nishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoko","family":"Sameshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Takagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhide","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,12,14]]},"reference":[{"key":"1487_CR1","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1182\/blood-2008-11-163501","volume":"113","author":"S Malinge","year":"2009","unstructured":"Malinge S, Izraeli S, Crispino JD. Insights into the manifestations, outcomes, and mechanisms of leukemogenesis in Down syndrome. Blood. 2009;113:2619\u201328.","journal-title":"Blood"},{"key":"1487_CR2","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1182\/blood-2007-01-069542","volume":"110","author":"SR Pine","year":"2007","unstructured":"Pine SR, Guo Q, Yin C, Jayabose S, Druschel CM, Sandoval C. Incidence and clinical implications of GATA1 mutations in newborns with Down syndrome. Blood. 2007;110:2128\u201331.","journal-title":"Blood"},{"key":"1487_CR3","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0272-2712(18)30133-1","volume":"19","author":"A Zipursky","year":"1999","unstructured":"Zipursky A, Brown EJ, Christensen H, Doyle J. Transient myeloproliferative disorder (transient leukemia) and hematologic manifestations of Down syndrome. Clin Lab Med. 1999;19:157\u201367.","journal-title":"Clin Lab Med"},{"key":"1487_CR4","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1136\/jcp.2003.12039","volume":"57","author":"RP Bajwa","year":"2004","unstructured":"Bajwa RP, Skinner R, Windebank KP, Reid MM. Demographic study of leukaemia presenting within the first 3\u00a0months of life in the Northern Health Region of England. J Clin Pathol. 2004;57:186\u20138.","journal-title":"J Clin Pathol"},{"key":"1487_CR5","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1001\/jama.1954.73690210004006b","volume":"155","author":"GJ Schunk","year":"1954","unstructured":"Schunk GJ, Lehman WL. Mongolism and congenital leukemia. J Am Med Assoc. 1954;155:250\u20131.","journal-title":"J Am Med Assoc"},{"key":"1487_CR6","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1046\/j.1365-2141.2000.02027.x","volume":"110","author":"B Lange","year":"2000","unstructured":"Lange B. The management of neoplastic disorders of haematopoiesis in children with Down\u2019s syndrome. Br J Haematol. 2000;110:512\u201324.","journal-title":"Br J Haematol"},{"key":"1487_CR7","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1182\/blood.V36.4.443.443","volume":"36","author":"T Nagao","year":"1970","unstructured":"Nagao T, Lampkin BC, Hug G. A neonate with Down\u2019s syndrome and transient abnormal myelopoiesis: serial blood and bone marrow studies. Blood. 1970;36:443\u20137.","journal-title":"Blood"},{"key":"1487_CR8","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","volume":"114","author":"JW Vardiman","year":"2009","unstructured":"Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. 2009;114:937\u201351.","journal-title":"Blood"},{"key":"1487_CR9","doi-asserted-by":"crossref","first-page":"4606","DOI":"10.1182\/blood-2005-06-2448","volume":"107","author":"GV Massey","year":"2006","unstructured":"Massey GV, Zipursky A, Chang MN, Doyle JJ, Nasim S, Taub JW, et al. A prospective study of the natural history of transient leukemia (TL) in neonates with Down syndrome (DS): Children\u2019s Oncology Group (COG) study POG-9481. Blood. 2006;107:4606\u201313.","journal-title":"Blood"},{"key":"1487_CR10","first-page":"392","volume":"15","author":"AC Homans","year":"1993","unstructured":"Homans AC, Verissimo AM, Vlacha V. Transient abnormal myelopoiesis of infancy associated with trisomy 21. Am J Pediatr Hematol Oncol. 1993;15:392\u20139.","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"1487_CR11","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1046\/j.1365-2141.2003.04229.x","volume":"120","author":"A Zipursky","year":"2003","unstructured":"Zipursky A. Transient leukaemia\u2014a benign form of leukaemia in newborn infants with trisomy 21. Br J Haematol. 2003;120:930\u20138.","journal-title":"Br J Haematol"},{"key":"1487_CR12","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1182\/blood-2007-10-118810","volume":"111","author":"JH Klusmann","year":"2008","unstructured":"Klusmann JH, Creutzig U, Zimmermann M, Dworzak M, Jorch N, Langebrake C, et al. Treatment and prognostic impact of transient leukemia in neonates with Down syndrome. Blood. 2008;111:2991\u20138.","journal-title":"Blood"},{"key":"1487_CR13","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3109\/08880019609033374","volume":"13","author":"A Zipursky","year":"1996","unstructured":"Zipursky A, Rose T, Skidmore M, Thorner P, Doyle J. Hydrops fetalis and neonatal leukemia in Down syndrome. Pediatr Hematol Oncol. 1996;13:81\u20137.","journal-title":"Pediatr Hematol Oncol"},{"key":"1487_CR14","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/j.1365-2141.2008.07231.x","volume":"142","author":"H Muramatsu","year":"2008","unstructured":"Muramatsu H, Kato K, Watanabe N, Matsumoto K, Nakamura T, Horikoshi Y, et al. Risk factors for early death in neonates with Down syndrome and transient leukaemia. Br J Haematol. 2008;142:610\u20135.","journal-title":"Br J Haematol"},{"key":"1487_CR15","first-page":"603","volume-title":"Nelson textbook of pediatrics","author":"N Ambalavanan","year":"2011","unstructured":"Ambalavanan N, Carlo WA. Jaundice and hyperbilirubinemia in the Newborn. In: Kligman RM, Stanton BF, Geme JS, Scgor NF, editors. Nelson textbook of pediatrics. Philadelphia: Elsevier; 2011. p. 603\u20135."},{"key":"1487_CR16","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/S0022-3476(77)80553-2","volume":"90","author":"RK Mathis","year":"1977","unstructured":"Mathis RK, Andres JM, Walker WA. Liver disease in infants. Part II: hepatic disease states. J Pediatr. 1977;90:864\u201380.","journal-title":"J Pediatr"},{"key":"1487_CR17","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1136\/adc.60.6.512","volume":"60","author":"MC Dick","year":"1985","unstructured":"Dick MC, Mowat AP. Hepatitis syndrome in infancy\u2013an epidemiological survey with 10\u00a0year follow up. Arch Dis Child. 1985;60:512\u20136.","journal-title":"Arch Dis Child"},{"key":"1487_CR18","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0022-3476(85)80282-1","volume":"106","author":"WF Balistreri","year":"1985","unstructured":"Balistreri WF. Neonatal cholestasis. J Pediatr. 1985;106:171\u201384.","journal-title":"J Pediatr"},{"key":"1487_CR19","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1542\/pir.33-7-291","volume":"33","author":"D Brumbaugh","year":"2012","unstructured":"Brumbaugh D, Mack C. Conjugated hyperbilirubinemia in children. Pediatr Rev. 2012;33:291\u2013302.","journal-title":"Pediatr Rev"},{"key":"1487_CR20","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/00005176-200408000-00001","volume":"39","author":"V Moyer","year":"2004","unstructured":"Moyer V, Freese DK, Whitington PF, Olson AD, Brewer F, Colletti RB, et al. Guideline for the evaluation of cholestatic jaundice in infants: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr. 2004;39:115\u201328.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"1487_CR21","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1053\/siny.2002.0103","volume":"7","author":"PJ McKiernan","year":"2002","unstructured":"McKiernan PJ. Neonatal cholestasis. Semin Neonatol. 2002;7:153\u201365.","journal-title":"Semin Neonatol"},{"key":"1487_CR22","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3109\/15513819009067127","volume":"10","author":"DM Becroft","year":"1990","unstructured":"Becroft DM, Zwi LJ. Perinatal visceral fibrosis accompanying the megakaryoblastic leukemoid reaction of Down syndrome. Pediatr Pathol. 1990;10:397\u2013406.","journal-title":"Pediatr Pathol"},{"key":"1487_CR23","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/0046-8177(91)90111-2","volume":"22","author":"ED Ruchelli","year":"1991","unstructured":"Ruchelli ED, Uri A, Dimmick JE, Bove KE, Huff DS, Duncan LM, et al. Severe perinatal liver disease and Down syndrome: an apparent relationship. Hum Pathol. 1991;22:1274\u201380.","journal-title":"Hum Pathol"},{"key":"1487_CR24","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1182\/blood.V80.6.1521.1521","volume":"80","author":"J Miyauchi","year":"1992","unstructured":"Miyauchi J, Ito Y, Kawano T, Tsunematsu Y, Shimizu K. Unusual diffuse liver fibrosis accompanying transient myeloproliferative disorder in Down\u2019s syndrome: a report of four autopsy cases and proposal of a hypothesis. Blood. 1992;80:1521\u20137.","journal-title":"Blood"},{"key":"1487_CR25","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/(SICI)1096-911X(199809)31:3<159::AID-MPO6>3.0.CO;2-A","volume":"31","author":"M Schwab","year":"1998","unstructured":"Schwab M, Niemeyer C, Schwarzer U. Down syndrome, transient myeloproliferative disorder, and infantile liver fibrosis. Med Pediatr Oncol. 1998;31:159\u201365.","journal-title":"Med Pediatr Oncol"},{"key":"1487_CR26","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/00043426-200201000-00004","volume":"24","author":"F Al-Kasim","year":"2002","unstructured":"Al-Kasim F, Doyle JJ, Massey GV, Weinstein HJ, Zipursky A. Incidence and treatment of potentially lethal diseases in transient leukemia of Down syndrome: Pediatric Oncology Group Study. J Pediatr Hematol Oncol. 2002;24:9\u201313.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"562\u20135","key":"1487_CR27","first-page":"e1","volume":"158","author":"AR Davis","year":"2011","unstructured":"Davis AR, Rosenthal P, Escobar GJ, Newman TB. Interpreting conjugated bilirubin levels in newborns. J Pediatr. 2011;158(562\u20135):e1.","journal-title":"J Pediatr"},{"key":"1487_CR28","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00431-010-1363-8","volume":"170","author":"R Bruyne De","year":"2011","unstructured":"De Bruyne R, Van Biervliet S, Vande Velde S, Van Winckel M. Clinical practice: neonatal cholestasis. Eur J Pediatr. 2011;170:279\u201384.","journal-title":"Eur J Pediatr"},{"key":"1487_CR29","first-page":"34","volume":"22","author":"M Sotomatsu","year":"2008","unstructured":"Sotomatsu M, Park MJ, Shimada A, hayashi Y. A case of Down syndrome with transient abnormal myelopoiesis and nonsyndromic paucity of interlobular bile ducts. Jpn J Pediatric Hematol. 2008;22:34\u20137.","journal-title":"Jpn J Pediatric Hematol"},{"key":"1487_CR30","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0022-3468(75)90107-4","volume":"10","author":"P Puri","year":"1975","unstructured":"Puri P, Guiney EJ. Intrahepatic biliary atresia in Down\u2019s syndrome. J Pediatr Surg. 1975;10:423\u20134.","journal-title":"J Pediatr Surg"},{"key":"1487_CR31","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1136\/adc.2006.101451","volume":"92","author":"DA Kelly","year":"2007","unstructured":"Kelly DA, Davenport M. Current management of biliary atresia. Arch Dis Child. 2007;92:1132\u20135.","journal-title":"Arch Dis Child"},{"key":"1487_CR32","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1182\/blood.V75.7.1540.1540","volume":"75","author":"T Terui","year":"1990","unstructured":"Terui T, Niitsu Y, Mahara K, Fujisaki Y, Urushizaki Y, Mogi Y, et al. The production of transforming growth factor-beta in acute megakaryoblastic leukemia and its possible implications in myelofibrosis. Blood. 1990;75:1540\u20138.","journal-title":"Blood"},{"key":"1487_CR33","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1046\/j.1365-2141.2001.03093.x","volume":"115","author":"H Hattori","year":"2001","unstructured":"Hattori H, Matsuzaki A, Suminoe A, Ihara K, Nakayama H, Hara T. High expression of platelet-derived growth factor and transforming growth factor-beta 1 in blast cells from patients with Down syndrome suffering from transient myeloproliferative disorder and organ fibrosis. Br J Haematol. 2001;115:472\u20135.","journal-title":"Br J Haematol"},{"key":"1487_CR34","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.leukres.2006.09.008","volume":"31","author":"A Shimada","year":"2007","unstructured":"Shimada A, Hayashi Y, Ogasawara M, Park MJ, Katoh M, Minakami H, et al. Pro-inflammatory cytokinemia is frequently found in Down syndrome patients with hematological disorders. Leuk Res. 2007;31:1199\u2013203.","journal-title":"Leuk Res"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-013-1487-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-013-1487-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-013-1487-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T01:51:57Z","timestamp":1597197117000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-013-1487-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,14]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["1487"],"URL":"https:\/\/doi.org\/10.1007\/s12185-013-1487-5","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,14]]}}}